Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Carisoprodol manufacturers

26 products found

Filters

26 products found

carisoprodol + paracetamol

Tablets 300 mg + 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #16196
The company is committed to providing and addressing healthcare needs as well as delivering patient care services across the globe. Through state of art facility, they have been working for more than 60 years and delivering nothing short of excellent.

Manufacturer usually replies in 10 days

carisoprodol + paracetamol

Tablets 200 mg + 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years. The company's production lines are GMP-compliant. Key production lines are Rx and OTC. Main therapeutic areas include the cardiovascular system, CNS, and diabetes. Main dosage forms include solid, liquid, semi-solid and injectable forms.

Manufacturer usually replies in 6 days

carisoprodol

Tablets 350mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #16207

Manufacturer usually replies in 3 days

carisoprodol

Tablets 250 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18870

Manufacturer usually replies in 9 days

carisoprodol

Tablets 350 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #17648

Manufacturer usually replies in 8 days

carisoprodol

Tablets 350 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

carisoprodol

Tablets 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20336

Manufacturer usually replies in 4 days

carisoprodol

Tablets 350 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

carisoprodol + acetylsalicylic acid + caffeine

Tablets 200 mg + 160 mg + 32 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bolivia
GMP approvals
WHO
Manufacturer #17273
The company was formed more than 80 years ago. They develop and market health, beauty, and wellness products. They are committed to excellence in service and quality, and responsibility to society. They have Divided pharmaceuticals into five sections: large volume solutions (serums), small volume solutions (injectables), powders, liquids, and solids.

Manufacturer usually replies in 3 days

carisoprodol

Tablets 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bolivia
GMP approvals
WHO
Manufacturer #17273
The company was formed more than 80 years ago. They develop and market health, beauty, and wellness products. They are committed to excellence in service and quality, and responsibility to society. They have Divided pharmaceuticals into five sections: large volume solutions (serums), small volume solutions (injectables), powders, liquids, and solids.

Manufacturer usually replies in 3 days

carisoprodol + paracetamol

Tablets 200mg + 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16247
The pharmaceutical company is currently in 120+ presentations corresponding to 50+ products that cover common clinical conditions, attended by a wide range of specialties. In Oncology and Special Treatments Line, which already has more than 3 products in more than 5 presentations, also venturing into the field of Pulmonology through a new Respiratory Line.

Manufacturer usually replies in 3 days

carisoprodol

Tablets 350mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16247
The pharmaceutical company is currently in 120+ presentations corresponding to 50+ products that cover common clinical conditions, attended by a wide range of specialties. In Oncology and Special Treatments Line, which already has more than 3 products in more than 5 presentations, also venturing into the field of Pulmonology through a new Respiratory Line.

Manufacturer usually replies in 3 days

carisoprodol

Capsules 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20576
The company is focused to produce good quality products for more than 50 years. The company believes that pharmaceutical work and product development can help improve the quality of life of people, no matter where they live. Poverty or wealth; health is priceless, they are duty-bound.

Manufacturer usually replies in 6 days

carisoprodol

Tablets 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

carisoprodol + paracetamol + caffeine

Tablets 175 mg + 352 mg + 32 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17808

Manufacturer usually replies in 14 days

carisoprodol + paracetamol

Tablets 175 mg + 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20598
The company has a PIC/S GMP-certified pharmaceutical factory that has been approved by the TFDA. In recent years, with the rapid development of science and technology, the mutual penetration and promotion of various disciplines have greatly promoted the development of pharmaceuticals. New methods, new technologies, new equipment, new ingredients and new ingredients in modern drug manufacturing continue to emerge. The basic research has been deepened, applied research has been more perfect, and the development of pharmaceutical dosage forms has entered the era of new drug release systems from traditional dosage forms such as tablets, capsules, and injections. New products of various controlled and sustained-release dosage forms are on the market, and the research on targeted drug delivery preparations and pulse-controlled automatic drug delivery systems is developing rapidly.

Manufacturer usually replies in 18 days

carisoprodol

Tablets 250 mg, 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20598
The company has a PIC/S GMP-certified pharmaceutical factory that has been approved by the TFDA. In recent years, with the rapid development of science and technology, the mutual penetration and promotion of various disciplines have greatly promoted the development of pharmaceuticals. New methods, new technologies, new equipment, new ingredients and new ingredients in modern drug manufacturing continue to emerge. The basic research has been deepened, applied research has been more perfect, and the development of pharmaceutical dosage forms has entered the era of new drug release systems from traditional dosage forms such as tablets, capsules, and injections. New products of various controlled and sustained-release dosage forms are on the market, and the research on targeted drug delivery preparations and pulse-controlled automatic drug delivery systems is developing rapidly.

Manufacturer usually replies in 18 days

carisoprodol

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20386

Manufacturer usually replies in 65 days

carisoprodol

Tablets 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #9692

Manufacturer usually replies in nan days

tapentadol hydrochloride + carisoprodol

Tablets 125 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20110

Manufacturer usually replies in 2 days

Want to view all 26 products? Create your free account today!

Carisoprodol is a centrally acting muscle relaxant belongs to a class of drugs called - skeletal muscle relaxants. Carisoprodol does not act directly on skeletal muscle but acts directly on the central nervous system. Carisoprodol is used short-term to treat muscle pain and discomfort. It is used to relax certain muscles in the body and relieve the discomfort caused by painful muscle or bone conditions. Carisoprodol is usually used along with rest, physical therapy and other treatments. It works by helping to relax the muscles. Carisoprodol is advised as a prescription product, generic prescription product as well as the mixture product. Manufacturers of Carisoprodol market these drugs under the Brand name of Soma, Vanadom. This drug is available by itself in a tablet or in combination with aspirin or in a fixed dose combination with both aspirin and codeine. Carisoprodol is available in the dosage form of Tablet which is administered orally. This drug is available in dosage strengths of 250 mg and 350 mg round, convex, white tablets inscribed with SOMA 250, SOMA 350 which are available in bottles of 100. It is slightly soluble in water and freely soluble in alcohol. This medication is available only with doctor’s prescription and the dosage is based on the medical condition and response to treatment. The recommended daily dose of Carisoprodol 250 mg and 350 mg is for every 8 hours and bed time. It can be taken with or without food as directed by physician. This medication should be used only for short-term (for 3 weeks or less) unless directed by physician. Immediate stop of this medication may have withdrawal symptoms such as headache, nausea, stomach cramps, trouble in sleeping and to avoid these symptoms one should lower the dose slowly with proper consultation. This medication is not recommended in pediatric patients less than 16 years of age. Carisoprodol tablets should be stored in well-closed containers at a temperature of 25 C (77 F) with excursions permitted between 15 and 30 C (59 and 86 F), away from light and moisture. Wholesale Price of Carisoprodol The wholesale price of Carisoprodol 350 mg ranges from $ 7.50 - $18.34 for 30 tablets and are also available for the unit price as low as $0.01 - $0.30 for a set of 1000 tablets in US. And the per unit cost of 250 mg tablets is approximately $ 6.87 for a set of 100 tablets. Carisoprodol - Mechanism of Action Carisoprodol is a central nervous system depressant that acts as a sedative and skeletal muscle relaxant. Rather than acting directly on the skeletal muscle, carisoprodol interrupts neuronal communication within the reticular formation and spinal cord resulting in sedation and alteration in pain perception. The abuse potential of this drug is associated to its ability to alter GABAA function (Gamma aminobutyric acid. This drug has been shown to modulate a variety of GABAA receptor subunits. GABAA receptor modulation can lead to anxiolysis due to inhibitory effects of neurotransmission. Finding Carisoprodol Manufacturers and Suppliers To find an honest partner in our business is one of the big tests and to defeat that test and to make one’s work / life easy in finding the honest manufacturer and supplier of Carisoprodol one can visit the Pipelinepharma website which helps buyer in finding the dependable manufacturers and suppliers of Carisoprodol. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.